| Pharmaceutical active ingredients: |
| Rabies Immune Globulin |
| Available forms, composition and doses of Imogam Rabia: |
| N / A |
| Imogam Rabia medical category: |
| Human:Vaccines, antisera and immunologicals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J06BB05 - Rabies Immunoglobulin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Related documents and information about Imogam Rabia: |
| Imogam Rabies prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
ImmuCyst | Bacillus Calmette-Guerin (BCG) Substrain Connaught | Sanofi-Aventis; Alfa Wassermann; Cambridge Laboratories; CytoChemia; Gerolymatos; Inibsa Laboratorios; Zuellig Pharma; Zuoz Pharma |
| Immunoglobuline Equine Tetanique Pasteur | Immune Globulin F Tetanus Equine | Sanofi-Aventis |
| Immunoglobullins | Antiserum to Human Immune Globulin liquid animal; Immune Globulin A Human Serum Goat; Immune Globulin M Human Serum Goat | Sanofi-Aventis |
| Imogam | Rabies Immune Globulin | Sanofi-Aventis |
| Imogam 16 | Immune Globulin Normal | Sanofi-Aventis |
| Imogam Rabies | Immune Globulin Human-Rabies | Sanofi-Aventis; ProMedico; Ranbaxy |
| Imogam Rabies Pasteurized | Immune Globulin Human-Rabies | Sanofi-Aventis |
| Imogam Rage | Immune Globulin Anti-Rabiques Human | Sanofi-Aventis |
| Imogam Tetano | Tetanus Immune Globulin | Sanofi-Aventis |
| Imogam Tetanos | Tetanus Immune Globulin | Sanofi-Aventis |